Abstract: Provided herein include apparatuses, devices, kits, and systems for rearing and deploying an arthropod, such as an aquatic insect, e.g., a mosquito. Methods of controlling arthropod populations for arthropod pest control and/or arthropod-home disease control are also disclosed. The compositions and methods disclosed herein are especially useful for high density release of arthropod in an efficient and labor-saving way.

Abstract: The present invention relates to a method of reducing the rate of decline in lung function in a human patient with COPD, wherein the human patient having COPD has a blood eosinophil count of ?150 cells/?L, and further wherein the method comprises administering to the patient an inhaled pharmaceutical product comprising fluticasone furoate.

Abstract: The present invention relates to pharmaceutical products comprising fluticasone furoate for use in the treatment of COPD patients, particularly a subgroup of COPD patients that through analysis have been identified as possessing an eosinophil blood count of ?150 cells/?l. The present invention is further directed to methods for treating a patient with COPD which methods include identifying a patient that will respond to treatment and administering a pharmaceutical product of the present invention comprising fluticasone furoate to said patient.

Abstract: The present invention relates to pharmaceutical products comprising fluticasone furoate for use in the treatment of COPD patients, particularly a subgroup of COPD patients that through analysis have been identified as possessing an eosinophil blood count of?150 cells/W. The present invention is further directed to methods for treating a patient with COPD which methods include identifying a patient that will respond to treatment and administering a pharmaceutical product of the present invention comprising fluticasone furoate to said patient.